Table 2.
Annual square root transformed change in CAC associated with novel risk factors among 1,123 CRIC study participants
| Variablesa | Multivariable model 1b | Multivariable model 2c | ||
|---|---|---|---|---|
| Square root transformed change in Agatston units/year (95% CI) | p value | Square root transformed change in Agatston units/year (95% CI) | p value | |
| Estimated glomerular filtration rate (17.4 ml/min/1.73 m2) | −0.26 (−0.36, −0.16) | <0.001 | −0.20 (−0.31, −0.10) | <0.001 |
| Log (24-hour urine albumin, 0.53 g/24 hours) | 0.23 (0.12, 0.33) | <0.001 | 0.14 (0.02, 0.25) | 0.02 |
| Cystatin C (0.66 mg/L) | 0.29 (0.19, 0.39) | <0.001 | 0.25 (0.15, 0.34) | <0.001 |
| Calcium (0.52 mg/dL) | −0.20 (−0.30, −0.10) | <0.001 | −0.17 (−0.27, −0.07) | <0.001 |
| Phosphate (0.68 mg/dL) | 0.21 (0.11, 0.31) | <0.001 | 0.14 (0.03, 0.24) | 0.009 |
| Log (fibroblast growth factor-23, 0.82 RU/mL) | 0.28 (0.19, 0.38) | <0.001 | 0.24 (0.14, 0.33) | <0.001 |
| Log (total parathyroid hormone, 0.67 pg/mL) | 0.18 (0.08, 0.27) | <0.001 | 0.13 (0.04, 0.23) | 0.007 |
| Alkaline phosphatase (31.2 U/L) | −0.02 (−0.12, 0.07) | 0.63 | −0.07 (−0.17, 0.02) | 0.14 |
| Hemoglobin A1c (1.37%) | 0.20 (0.11, 0.30) | <0.001 | 0.10 (−0.03, 0.22) | 0.12 |
| Log (HOMA-insulin resistance, 0.62) | 0.13 (0.03, 0.23) | 0.01 | 0.03 (−0.08, 0.14) | 0.59 |
| Uric acid (1.84 mg/dL) | 0.07 (−0.03, 0.17) | 0.19 | 0.03 (−0.07, 0.14) | 0.51 |
| Homocysteine (4.93 μmol/L) | 0.08 (−0.02, 0.19) | 0.13 | 0.02 (−0.08, 0.13) | 0.66 |
| Fibrinogen (1.10 mg/dL) | 0.15 (0.05, 0.25) | 0.002 | 0.08 (−0.02, 0.18) | 0.10 |
| Log (high sensitive C-reactive protein, 0.80 mg/L) | 0.02 (−0.08, 0.12) | 0.66 | 0.04 (−0.06, 0.13) | 0.45 |
| Log (interleukin-6, 0.57 pg/mL) | 0.18 (0.08, 0.28) | <0.001 | 0.17 (0.07, 0.27) | <0.001 |
| Log (tumor necrosis factor-α, 0.52 mg/dL) | 0.15 (0.05, 0.25) | 0.004 | 0.12 (0.02, 0.22) | 0.02 |
One standard deviation increase.
Adjusted for age, sex, race/ethnicity, clinical site, and baseline CAC score.
Adjusted for age, sex, race/ethnicity, clinical site, baseline CAC score, total cholesterol, HDL cholesterol, systolic BP, use of antihypertensive medications, diabetes, current smoking, history of CVD, use of statin medications, and physical activity.